Class of Stock [Axis] Common Stock, par value $0.0001 per share Warrants, exercisable for one share of common stock Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Members Capital [Member] Retained Earnings [Member] AOCI Attributable to Parent [Member] Measurement Frequency [Axis] Fair Value, Recurring [Member] Investment Type [Axis] Money Market Fund [Member] Mutual Fund [Member] Long-Lived Tangible Asset [Axis] Equipment [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Furniture and Fixtures [Member] Computer Equipment [Member] Leasehold Improvements [Member] Construction in Progress [Member] Preferred Units by Name [Axis] Preferred Units Class F [Member] Preferred Units Class G [Member] Legal Entity [Axis] CTx Board [Member] Plan Name [Axis] Equity Incentive Plan (PIU) [Member] Income Statement Location [Axis] General and Administrative Expense [Member] Selling and Marketing Expense [Member] Exercise Price Range [Axis] Distribution Threshold $25 Million [Member] Distribution Threshold $40 Million [Member] Distribution Threshold $75 Million [Member] Distribution Threshold $80 Million [Member] Distribution Threshold $90 Million [Member] Distribution Threshold $120 Million [Member] Distribution Threshold $160 Million [Member] Distribution Threshold [Member] Business Acquisition [Axis] Reorganization Merger [Member] Sale of Stock [Axis] IPO [Member] 2021 Equity Incentive Plan [Member] Award Type [Axis] Equity Option [Member] Antidilutive Securities [Axis] Share-Based Payment Arrangement, Option [Member] Warrant [Member] Indefinite-Lived Intangible Assets [Axis] Licensing Agreements [Member] Phase 3 Clinical Trial [Member] New Drug Application [Member] CTx-1301 and CTx-1302 [Member] CTx-2103 [Member] CTx-2103 [Member] Vesting [Axis] CTx-1301 [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS Current assets: Cash and cash equivalents Short-term investments Miscellaneous receivables Prepaid expenses and other current assets Total current assets Property and equipment, net Operating lease right-of-use assets Total assets LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable Accrued expenses Current installments of obligations under finance leases Other current liabilities Total current liabilities Long-term liabilities: Obligations under finance leases Operating lease liabilities Total liabilities Stockholders’ Equity Common Stock, $0.0001 par value; 240,000,000 shares authorized and 11,309,412 shares issued and outstanding as of March 31, 2022 and December 31, 2021 Preferred Stock, $0.0001 par value; 10,000,000 shares authorized and 0 shares issued and outstanding as of December 31, 2021 Additional Paid-in-Capital Accumulated other comprehensive income Accumulated deficit Total stockholders’ equity Total liabilities and stockholders’ equity Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Income Statement [Abstract] Operating expenses: Research and development General and administrative Operating loss Interest and other income (expense), net Loss before income taxes Income tax benefit (expense) Net loss Other comprehensive income (loss): Change in unrealized gain on short-term investments Comprehensive loss Net loss per share of common stock, basic and diluted Weighted average number of shares used in computing net loss per share of common stock, basic and diluted Beginning balance, value Beginning balance, shares Member contributions Net loss Unrealized losses on available for sale investments Stock-based compensation expense Ending balance, value Ending balance, shares Statement of Cash Flows [Abstract] Operating activities: Adjustments to reconcile net loss to net cash used in operating activities: Depreciation Stock-based compensation Other Changes in operating assets and liabilities: Miscellaneous receivables Prepaid expenses and other current assets Operating lease right-of-use assets Trade accounts payable and accrued expenses Other current liabilities Operating lease liabilities Net cash used in operating activities Investing activities: Purchase of property and equipment Net cash used in investing activities Financing Activities: Members’ capital contributions Proceeds from notes payable Principal payments on finance lease obligations Net cash provided by financing activities Cash and cash equivalents: Net increase in cash and cash equivalents Cash and cash equivalents at beginning of year Cash and cash equivalents at end of year Non-cash activities Property and equipment accrued but not yet paid at end of period Cash payments: Interest paid Accounting Policies [Abstract] Nature of the Business and Liquidity Summary of Significant Accounting Policies Fair Value Disclosures [Abstract] Fair Value of Assets and Liabilities Property, Plant and Equipment [Abstract] Property and Equipment Payables and Accruals [Abstract] Accrued Expenses Equity [Abstract] Members’ Capital Retirement Benefits [Abstract] Profits Interest Plan Stockholders’ Equity Share-Based Payment Arrangement [Abstract] Stock-Based Compensation Income Tax Disclosure [Abstract] Income Taxes Earnings Per Share [Abstract] Net Loss Per Share Organization, Consolidation and Presentation of Financial Statements [Abstract] License Agreement Related Party Transactions [Abstract] Related Party Transactions Subsequent Events [Abstract] Subsequent Events Basis of Presentation and Principles of Consolidation Unaudited Interim Financial Information Concentration of Credit Risk Miscellaneous Receivables Impairment of Long-lived Assets Stock-Based Compensation Schedule of Assets Measured and Carried at Fair Value on Recurring Basis Schedule of Property and Equipment Schedule of Accrued Expenses Schedule of Various Distribution Thresholds Summary of Option Activity Schedule of Fair Value Assumption Schedule of Effective Income Tax Rate Reconciliation Schedule of Deferred Tax Assets and Liabilities Schedule of Net Loss Per Share Basic And Diluted Schedule of Potentially Dilutive Securities Federal deposit insurance corporation limit Impairment of long lived assets Fair Value, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Amortized Cost Gross Unrealized Gain Gross Unrealized Loss Fair Value of Current Assets Fair Value of Non-Current Assets Fair Value of Total Assets Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property and equipment, gross Property and equipment, estimated useful life Less: accumulated depreciation Property and equipment, net Depreciation expense Professional and consulting fees Research and development CIP- Equipment Other Accrued Expenses Schedule of Preferred Units [Table] Preferred Units [Line Items] Preferred units, issued Preferred units, authorized Issuance of preferred uniits Share-Based Payment Arrangement, Option, Exercise Price Range [Table] Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] 2017 2018 2019 2020 2021 Total Schedule of Defined Benefit Plans Disclosures [Table] Defined Benefit Plan Disclosure [Line Items] Vesting period Stock option, granted Stock option, issued Remaining shares issued Conversion of stock, amount Conversion of stock into common shares Noncash compensation expense Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary, Sale of Stock [Line Items] Number of shares of common stock issued Share issued price per share Proceeds from public offering Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Number of Shares Common stock options, outstanding at Beginning Balance Weighted Average Exercise Price, Outstanding Beginning Balance Weighted Average Remaining Contractual Life (Years) Outstanding, Ending Number of Shares, Granted Weighted Average Exercise Price, Granted Weighted Average Remaining Contractual Term, Grants Number of Shares, Exercised Number of Shares, Forfeitures or expirations Number of Shares Common stock options, outstanding at Beginning balance Weighted Average Exercise Price, Outstanding Ending Balance Aggregate intrinsic value Shares, Vested and expected to vest Shares, Exercisable Risk-free interest rate Weighted-average expected term (in years) Expected volatility Expected dividend yield Number of shares common stock options Share based compensation, description Stock-based compensation expense Unrecognized compensation cost Grant-date fair value of options Share-based compensation arrangements aggregate intrinsic value Federal income tax benefit at statutory rate State income tax benefit Permanent differences Change in valuation allowance Other Total income tax expense Research and development costs Unvested stock options Other Patents Net operating losses Other Gross deferred income tax assets Less: valuation allowance Net deferred income tax asset Accrual to cash Property and equipment Gross deferred income tax liabilities Net deferred tax asset (liability) Deferred income tax expense benefit Deferred tax assets valuation allowance Weighted average common shares outstanding Net loss per share, basic and diluted Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Total Milestone payment Accrued milestone payment Rental expense Warrants, exercisable for one share of common stock. Common Stock, par value $0.0001 per share. Members Capital [Member] Members capital contributions. Unrealized losses on short-term investments. Property and equipment accrued but not yet paid at end of period. Unaudited Interim Financial Information [Policy Text Block] Fair value of current assets. Fair value of non-current assets. Money Market Fund [Member] Accrued, research and development. Preferred Units Class F [Member] Preferred Units Class G [Member] CTx Board [Member] Equity Incentive Plan (PIU) [Member] Distribution Threshold $25 Million [Member] Distribution Threshold $40 Million [Member] Distribution Threshold $75 Million [Member] Distribution Threshold $80 Million [Member] Distribution Threshold $90 Million [Member] Distribution Threshold $120 Million [Member] Distribution Threshold $160 Million [Member] Distribution Threshold [Member] Incentive distribution distribution per year one. Incentive distribution distribution per year two. Incentive distribution distribution per year three. Incentive distribution distribution per year four. Incentive distribution distribution per year five. Reorganization Merger [Member] 2021 Equity Incentive Plan [Member] Deferred tax liabilities accrual to cash current. The value of milestone payment. Phase 3 Clinical Trial [Member] New Drug Application [Member] CTx-1301 and CTx-1302 [Member] CTx-2103 [Member] CTx-2103 [Member] Accrued milestone payment. CTx-1301 [Member] Deferred tax assets unvested stock options. Deferred tax assets other current. Income tax reconciliation permanent difference. Operating lease right-of-use assets. Weighted average remaining contractual term, grants. Unrealized losses on available for sale investments. CTx-2103 [Member] [Default Label] Assets, Current Assets Liabilities, Current Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Income (Loss) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Attributable to Parent Shares, Outstanding Other Noncash Income (Expense) Increase (Decrease) in Accounts and Notes Receivable Increase (Decrease) in Prepaid Expense and Other Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets Increase (Decrease) in Other Current Liabilities Increase (Decrease) in Operating Lease Liability Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Finance Lease, Principal Payments Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Stockholders' Equity Note Disclosure [Text Block] Compensation Related Costs, Policy [Policy Text Block] Equity Securities, FV-NI, Unrealized Loss Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment AccruedResearchAndDevelopmentCostsCurrent Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Effective Income Tax Rate Reconciliation, Other Adjustments, Amount DeferredTaxAssetsOtherCurrent Deferred Tax Assets, Other Deferred Tax Assets, Gross Deferred Tax Assets, Net of Valuation Allowance DeferredTaxLiabilitiesAccrualToCashCurrent Deferred Tax Liabilities, Property, Plant and Equipment Deferred Tax Liabilities, Gross Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount